Advancements in the diagnosis of biliopancreatic diseases: A comparative review and study on future insights.

IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY
Eyad Gadour, Bogdan Miutescu, Zeinab Hassan, Emad S Aljahdli, Khurram Raees
{"title":"Advancements in the diagnosis of biliopancreatic diseases: A comparative review and study on future insights.","authors":"Eyad Gadour, Bogdan Miutescu, Zeinab Hassan, Emad S Aljahdli, Khurram Raees","doi":"10.4253/wjge.v17.i4.103391","DOIUrl":null,"url":null,"abstract":"<p><p>Owing to the complex and often asymptomatic presentations, the diagnosis of biliopancreatic diseases, including pancreatic and biliary malignancies, remains challenging. Recent technological advancements have remarkably improved the diagnostic accuracy and patient outcomes in these diseases. This review explores key advancements in diagnostic modalities, including biomarkers, imaging techniques, and artificial intelligence (AI)-based technologies. Biomarkers, such as cancer antigen 19-9, <i>KRAS</i> mutations, and inflammatory markers, provide crucial insights into disease progression and treatment responses. Advanced imaging modalities include enhanced computed tomography (CT), positron emission tomography-CT, magnetic resonance cholangiopancreatography, and endoscopic ultrasound. AI integration in imaging and pathology has enhanced diagnostic precision through deep learning algorithms that analyze medical images, automate routine diagnostic tasks, and provide predictive analytics for personalized treatment strategies. The applications of these technologies are diverse, ranging from early cancer detection to therapeutic guidance and real-time imaging. Biomarker-based liquid biopsies and AI-assisted imaging tools are essential for non-invasive diagnostics and individualized patient management. Furthermore, AI-driven models are transforming disease stratification, thus enhancing risk assessment and decision-making. Future studies should explore standardizing biomarker validation, improving AI-driven diagnostics, and expanding the accessibility of advanced imaging technologies in resource-limited settings. The continued development of non-invasive diagnostic techniques and precision medicine approaches is crucial for optimizing the detection and management of biliopancreatic diseases. Collaborative efforts between clinicians, researchers, and industry stakeholders will be pivotal in applying these advancements in clinical practice.</p>","PeriodicalId":23953,"journal":{"name":"World Journal of Gastrointestinal Endoscopy","volume":"17 4","pages":"103391"},"PeriodicalIF":1.4000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12019128/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastrointestinal Endoscopy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4253/wjge.v17.i4.103391","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Owing to the complex and often asymptomatic presentations, the diagnosis of biliopancreatic diseases, including pancreatic and biliary malignancies, remains challenging. Recent technological advancements have remarkably improved the diagnostic accuracy and patient outcomes in these diseases. This review explores key advancements in diagnostic modalities, including biomarkers, imaging techniques, and artificial intelligence (AI)-based technologies. Biomarkers, such as cancer antigen 19-9, KRAS mutations, and inflammatory markers, provide crucial insights into disease progression and treatment responses. Advanced imaging modalities include enhanced computed tomography (CT), positron emission tomography-CT, magnetic resonance cholangiopancreatography, and endoscopic ultrasound. AI integration in imaging and pathology has enhanced diagnostic precision through deep learning algorithms that analyze medical images, automate routine diagnostic tasks, and provide predictive analytics for personalized treatment strategies. The applications of these technologies are diverse, ranging from early cancer detection to therapeutic guidance and real-time imaging. Biomarker-based liquid biopsies and AI-assisted imaging tools are essential for non-invasive diagnostics and individualized patient management. Furthermore, AI-driven models are transforming disease stratification, thus enhancing risk assessment and decision-making. Future studies should explore standardizing biomarker validation, improving AI-driven diagnostics, and expanding the accessibility of advanced imaging technologies in resource-limited settings. The continued development of non-invasive diagnostic techniques and precision medicine approaches is crucial for optimizing the detection and management of biliopancreatic diseases. Collaborative efforts between clinicians, researchers, and industry stakeholders will be pivotal in applying these advancements in clinical practice.

胆道胰腺疾病诊断的进展:比较回顾和未来见解的研究。
由于其复杂且通常无症状的表现,包括胰腺和胆道恶性肿瘤在内的胆胰疾病的诊断仍然具有挑战性。最近的技术进步显著提高了这些疾病的诊断准确性和患者预后。本综述探讨了诊断模式的主要进展,包括生物标志物、成像技术和基于人工智能(AI)的技术。生物标志物,如癌症抗原19-9、KRAS突变和炎症标志物,为疾病进展和治疗反应提供了重要的见解。先进的成像方式包括增强计算机断层扫描(CT)、正电子发射断层扫描(CT)、磁共振胆管造影和内窥镜超声。人工智能在成像和病理学方面的集成通过深度学习算法提高了诊断精度,这些算法可以分析医学图像,自动执行常规诊断任务,并为个性化治疗策略提供预测分析。这些技术的应用是多种多样的,从早期癌症检测到治疗指导和实时成像。基于生物标志物的液体活检和人工智能辅助成像工具对于非侵入性诊断和个性化患者管理至关重要。此外,人工智能驱动的模型正在改变疾病分层,从而增强风险评估和决策。未来的研究应探索标准化生物标志物验证,改进人工智能驱动的诊断,并在资源有限的情况下扩大先进成像技术的可及性。非侵入性诊断技术和精准医学方法的持续发展对于优化胆胰疾病的检测和管理至关重要。临床医生、研究人员和行业利益相关者之间的合作努力将是在临床实践中应用这些进步的关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Gastrointestinal Endoscopy
World Journal of Gastrointestinal Endoscopy GASTROENTEROLOGY & HEPATOLOGY-
自引率
5.00%
发文量
1164
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信